A class of drugs used to lower down the cholesterol of a person was announced by the Federal regulators to be added with additional warnings to the labels on these statins.
Statins slow down the enzyme that is responsible in the liver’s production of cholesterol. Common brands of these are known with their brand names Crestor, Lipitor and Zocor.
The U.S. Food and Drug and Administration or the FDA, requires that statins must have added warnings in their labels. Warnings should include the risks of liver damage, type 2 diabetes, memory loss and confusion. Statins particularly the lovastatin was found to be contributing to the increasing risk of muscle weakness.
After the decision has made by the agency, it was followed up with an internal meeting between the FDA's Office of Surveillance and Epidemiology and Office of New Drugs.
There is a small anecdotal reports reviewed found especially on the effects of statins on memory loss, according to Dr. Amy Egan, the FDA's deputy director of safety in the division of metabolism drug products. The warning for memory loss of this statins has found to be more serious type of cognitive problems than simple forgetfulness, he added.
Regarding with the new warnings, Egan continued that they cannot establish of causality with statin therapy.
The evaluation of the effects of statins by the division was all just short-term studies and the long-term effects of statin therapy was shown to be unclear. Egan said, to better understand how risky to use the statin at some conditions, it should be determined by the division which statins increase the effects listed in the warnings and what dose contributes to the risk.
But, the experts have pronounced that they had seen effects in some of their patients. Although the need for liver-monitoring test was then removed from the statin labels, many of the experts were still on the concern of the continuing the prescribed tests for their patients.
Dr. Andrew Carroll, a physician at the Renaissance Medical Group in Phoenix, disagree with the notion that they can halt checking for liver function test abnormalities for he said he saw high liver enzymes for around five percent of the patients whom received prescribed statins. This was also made him to recommend the patients to not continue the medication.
However, for many experts, they suggest that patients should not be discouraged of using the statins because of the added warnings in the statin labels. Instead, patients should have to report any side effects to their doctors that they may be experiencing.
Catherine Cooper, a passionate writer and a party goer but hardworking person, likes to unwind and a soak in a hot tub spa is her way of relaxing. The hot tub machine is her favorite amenity at home. It gives her the reason to stay healthy and happy.